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ABSTRACT The blocking action of aminopyridines on an inactivating K current (IKi) in GH3 pituitary cells was studied before
and after altering the macroscopic decay of the current with /N-bromoacetamide (NBA). The first depolarizing pulse delivered
either seconds or minutes after beginning 4-aminopyridine (4AP) application, elicited a current with both a more rapid decay
and a reduced peak amplitude. The rapid decay (or time-dependent block) was especially prominent in NBA-treated cells.
With continued drug application, subsequent test pulses revealed a stable block of peak current, greater in NBA-treated than
control cells. Recovery from block was enhanced by hyperpolarizing holding potentials and by the first depolarizing pulse
delivered after prolonged recovery intervals. Unlike aminopyridine block of other K currents, there was no convincing
evidence for voltage shifts in activation or inactivation, or for voltage and frequency-dependent unblock. Increasing the open
probability of the channels did, however, facilitate the block. Although the behavior of currents in 4AP was suggestive of
"open channel block," the block was not produced by 4-aminopyridine methiodide, a positively charged aminopyridine.
Moreover, because partial block and recovery occurred without opening the channels we suggest that aminopyridines bind
to, or near, this K channel, that this binding is enhanced by opening the channel, and that a conformational change is induced
which mimics inactivation. Because recovery from block is enhanced by negative potentials, we suggest that aminopyridine
molecules may become "trapped" by inactivation awaiting the slow process of reactivation to escape their binding sites.
INTRODUCTION
Block of delayed rectifier and 'A type potassium currents
by 4-aminopyridine (4AP) has been described in a wide
variety of cell types ranging from neurons and T lympho-
cytes to cardiac ventricular cells (e.g., Yeh et al., 1976;
Chandy et al., 1984; Josephson et al., 1984). In such cells,
aminopyridines have proven useful agents for the separa-
tion of K channel subtypes. For example, the K channel
which may be responsible for prolonging the cardiac
ventricular action potential plateau at short diastolic
intervals is a 4AP sensitive transient outward current
(Hiraoka and Kawano, 1987). Aminopyridines have also
proven useful in augmenting the release of transmitter at
nerve terminals (Thesleff, 1980; Bondy and Russell,
1988) and hormones from pituitary cells (Sand et al.,
1980; Schofield and Saith, 1981) suggesting that aminopy-
ridine-sensitive K channels may play an important role in
the regulation of neurosecretion.
Recently a potassium current IL, with complex inacti-
vation gating kinetics was described in GH3 pituitary cells
(May and Oxford, 1986; Wagoner and Oxford, 1987;
Oxford and Wagoner, 1989). In whole-cell recording
conditions, this current is blocked by either internal or
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external application of aminopyridines. Moreover, in
on-cell or excised membrane patches, minicurrents, repre-
senting several activated channels, are also blocked by
4AP.
In previous reports on many different cell types, ami-
nopyridines have been shown to interact with K channels
in complex ways resulting in such phenomena as fre-
quency and voltage-dependent unblock. In contrast, we
now describe in GH3 cells a block of IKL by 4AP which
exhibits neither voltage- nor frequency-dependent un-
block, but instead reveals a marked time-dependent
block. We suggest that the absence of the usual pulse-
dependent unblocking features in this channel may reflect
more than one pathway to and from the 4AP blocking
site(s), as well as the unusually slow process of recovery
from inactivation characteristic of these channels (Oxford
and Wagoner, 1989).
METHODS
GH3 cells were obtained from the American Type Culture Collection
(Rockville, MD). Culture and recording conditions have been previously
described (Oxford and Wagoner, 1989). We used either a List EPC-7
(Medical Systems, Greenvale, NY) or an Axopatch (Axon Instruments
Inc., Burlingame, CA) voltage clamp in combination with either a
custom 12-bit analog-to-digital converter interfaced with a PDP-1 1/23
computer or a Scientific Solutions Labmaster A/D board interfaced to
an IBM-AT (IBM Instruments Inc., IBM Corp., Danbury, CT). Data
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acquisition and analysis routines were developed under the C-LAB
programming environment (INDEC Systems, Sunnyvale, CA). Before
digitization, current signals were low-pass filtered at 5-10 kHz (-3 dB,
4-pole Bessel). A - P/4 averaging procedure (Armstrong and Bezanilla,
1977) was used to delete residual linear leakage and capacitive currents
not completely corrected by analogue compensation. Approximately
80% of the total series resistance was electronically compensated.
The standard extracellular recording solution contained (mM): 4
MgCl2, 1 EGTA (ethyleneglycol-bis-(beta-aminoethylether)N-N'-
tetraacetic acid) (free Mg2+ -3.7), 5 TEA (tetraethylammonium) Cl, 5
KCI, 135 NaCl, and 300 nM tetrodotoxin. The standard internal
solution was (millimolar): 120 K aspartate, 20 KCI, 1 MgCl2, 2 Mg -
ATP, 1 cyclic AMP, 10 EGTA (free Mg2, -1.5), 5 disodium creatine
phosphate (CP), 20 U/ml creatine phosphokinase (CPK). All solutions
contained 10 mM Hepes (N-2-hydroxyethylpiperazine-N'-2-ethanesul-
phonic acid) buffer and 10 mM D-glucose with pH and osmolality
adjusted to -7.4 and 300 mosM, respectively. Assuming 3 MM contami-
nating calcium from salts used to make the solutions, the free [Ca2+] in
the external solution was <2 x 10-`0 M and in the internal solution was
<2 x 10-" M. The stability constants used in the calculation of free
[Ca2,] were from Owen (1976) and Chaberek and Martell (1959). We
have previously demonstrated that use of these solutions, along with the
voltage protocols described in this paper, adequately eliminates any
significant contributions of currents, other than IKi to the records
(Oxford and Wagoner, 1989). Aminopyridines were obtained from
Aldrich Chemical Co. (Milwaukee, WI). All other chemicals including
N-bromoacetamide (NBA) and 4-acetamido-4'-isothiocyanostilbene-2-
2'-disulphonic acid (SITS) were obtained from Sigma Chemical Co. (St.
Louis, MO). The quaternary 4-aminopyridine methiodide (4-APMI)
was prepared according to the methods of Poziomek (1963) and
recrystallized from ethanol. NBA and 4AP were prepared daily for each
experiment and were applied to the external membrane surface either by
continuous bath infusion or via a U-tube as previously described
(Oxford and Wagoner, 1989). In some experiments 4AP was applied
internally using a system of catheters to exchange the pipette solution
during an experiment. The design of the exchange apparatus was similar
to that described previously (e.g., Cull-Candy et al., 1981).
The terminology associated with ion-channel gating and drug block is,
unfortunately, not standardized and multiple meanings for several terms
have evolved. We have adopted the following interpretations to associate
with certain terms in this paper. Frequency dependence refers to the
influence of multiple repetitive voltage steps at intervals of0.5-5 s on the
state of aminopyridine block. Use dependence is a more general term
that refers to the dependence of aminopyridine block on activation of the
channel regardless of frequency. Inactivation is used to describe the
phenomenon of decay of macroscopic K current during a maintained
depolarization in the absence of aminopyridines and does not here imply
a particular channel state transition in any kinetic scheme for gating.
Time-dependent, open channel
block of IKI by 4AP
After rapid application (time constant 100 ms) of
0.05-1.0 mM 4AP via an U -tube, voltage steps delivered
within 5-15 s elicited currents having an increased rate of
decay when compared to control currents. For example,
although 1 mM 4AP only slightly reduced peak current
after 10 s (Fig. 1 A), it noticeably increased the macro-
scopic decay rate. Similar results were obtained with 3AP
(data not shown).
The increase in the rate of decay of IKi was more
pronounced in cells treated with NBA (Wagoner and
Oxford, 1987; Matteson and Carmeliet, 1988; Oxford and
Wagoner, 1989). For example, after the dramatic slowing
of the current decay by 50 ,M NBA, a 10-s exposure to 1
mM 4AP reestablished a marked time-dependent decline
(Fig. 1 B) which closely approximated the normal time
course before NBA treatment. The acceleration of decay
rate was dose dependent as seen in another NBA-treated
cell in Fig. 1 C. In this case, a 15-s application of 100 ,uM
4AP increased the rate of the decay of the current during
the voltage step. After washing away the 4AP, the current
recovered the slow decay characteristic of NBA-treated
cells. A subsequent 15-s exposure of the same cell to 1
mM 4AP yielded a dramatic acceleration of the decay.
Computer subtraction of 4AP traces from their corre-
sponding NBA traces yielded time courses of 4AP block
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RESULTS
External application of aminopyridines to GH3 cells
induces two changes in the transient outward current, IKi.
First, aminopyridines produce a time-dependent block
which accelerates the decay of the macroscopic current.
Second, these compounds cause a more slowly progressing
block which reaches equilibrium (stable block) after
several minutes and is recorded as a reduction in peak
current.
FIGURE 1 Time-dependent block of IKi by 4AP. (A) Decay of IKi in
control cells is accelerated during early exposure to 4AP. Records
represent current responses at +40 mV for control conditions (upper
trace), and after lO s (lower trace) of exposure to 1 mM 4AP. (B) Early
block of IKi by 1 mM 4AP in NBA-treated cells mimics the normal
decay of current. Traces represent control IKi' current during application
of 50 uM NBA, and current after a 10 s exposure to 1 mM 4AP + 50
gM NBA. (C) Current records were obtained at +20 mV after NBA
treatment and subsequent 15 s exposures to 100 gM or 1 mM 4AP as
indicated for each trace. IKi was allowed to recover between applications
of 4AP. In all panels, holding potential = -60 mV and dashed line
represents zero current.
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which were fit by single exponentials with time constants A
of 61.4 and 24.2 ms for 0.1 and 1 mM 4AP, respectively.
These observations are reminiscent of the local anesthetic
induced "inactivation" of Na currents in pronase-treated
axons (e.g., Cahalan, 1978) or the effects of long-chain
quaternary ammonium compounds on delayed rectifier K
currents (Armstrong, 1971).
A quaternary aminopyridine does
not block IKI
Open channel or voltage-dependent block mechanisms
are typically associated with the charged state of drug
molecules. In particular, quaternary compounds with
permanent positive charges have been used to demon-
strate the requirement of charge for block. Such com-
pounds have also been useful in determining from which
side(s) of the membrane the blocking reaction proceeds
(e.g., Yeh, 1982). For example, 4-aminopyridine methio-
dide (4-APMI) has been shown to block delayed rectifier
K channels only when applied to the cytoplasmic side of
the channels (Kirsch and Narahashi, 1983). However,
when we examined block of IKi by 4-APMI, we found no
evidence of block by this analogue at concentrations as
high as 5 mM whether applied externally (n = 5) or
internally (n = 4). This finding suggests that neutral
aminopyridine molecules may be the most active form in
blocking IKi. However, the possibility that steric rather
than coulombic barriers prohibit block by 4-APMI can-
not be excluded.
Closed channel block Of IKI by
aminopyridines
During 4AP application the first test pulse to assess block
revealed not only the increase in rate of decay described
above, but also a reduction of peak current. This pattern
was observed with either brief (Fig. 2 A) or prolonged
(Fig. 2 B) applications of 4AP. This reduction in peak
current was present even when using very negative
holding potentials (e.g., - 90 mV) which greatly reduced
open channel probability. Exponentials were fit to the
decay of each trace in Fig. 2 and extrapolated to the
beginning of the voltage step to estimate the degree of
block before channel opening. A 28% block preceded
macroscopic activation during the 30 s of exposure to 300
,sM 4AP in A (Vh = -60 mV), and a 36% block during
the 8-min exposure to 300 ,M 4AP in B (Vhb =-70 mV).
Similar analyses on three cells not pretreated with NBA
revealed an average "closed channel block" of42% during
exposures to 1 mM 4AP for 5-7.5 min.
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FIGURE 2 4AP block of "closed" channels proceeds slowly, but is
accelerated with channel opening. (A) Records represent consecutive
and exclusive current responses at +40 mV after pretreatment with 50
MAM NBA, and after 30 s and 2 min ofexposure to 300 ,uM 4AP + 50juM
NBA as labeled. Holding potential = -60 mV. (B) Records from
another NBA treated cell in which the first and second test pulses during
300 ,uM 4AP exposure were applied at 8 and 9 min, respectively. As in
A, these records were consecutive and exclusive. Holding potential =
- 70 mV.
Channel opening facilitates block
In spite of our evidence suggesting that 4AP can block
closed K channels, channel opening greatly facilitated
block. As can be seen in Fig. 2 B, after prolonged
application of 4AP, substantial IKi was elicited with the
first test pulse at 8 min. However, with the next voltage
step, delivered 1 min later, only a weak current was
elicited. The block had apparently increased after the
activation of channels in the first pulse. A further indica-
tion of the enhancement of block by channel opening is
the greatly diminished second pulse current (at 2 min) in
Fig. 2 A as compared to the first pulse current (at 8 min)
in Fig. 2 B, despite the fourfold longer 4AP exposure in
Fig. 2 B. Thus, comparison of the degree of block seen
during the first voltage step for short versus long duration
4AP exposures indicates that "closed channel" block
proceeds quite slowly. In contrast, comparisons between
the first and second pulse currents in Fig. 2, A or B,
indicate that "open channel" block proceeds more rap-
idly.
Stable block Of IKI by aminopyridines
Continued exposure to 4AP leads to a progressive decline
in peak current resulting in a stable, or steady-state block.
This is unlike the case of phasic block of other channels by
quaternary ions or local anesthetics where kinetic manifes-
tations of the block persist throughout the drug treat-
ment. Under equilibrium conditions, during continued
exposure to 4AP, currents were effectively reduced at all
potentials (Fig. 3 A and B), and could be blocked with
either external (Fig. 3 C) or internal (Fig. 3 D) applica-
tion. The percentage of peak current blocked by pro-
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FIGURE 3 External or internal 4-aminopyridine blocks IKi in GH3 cells.
(A) Family of control currents in response to 100 ms voltage steps from
-40 to +60 mV in 20 mV increments from a holding potential of -60
mV. Interpulse interval was 35 s. Standard internal and external
solutions were used. (B) Currents from same cell as shown in A, but after
bath application of 3.5 mM 4AP. Identical voltage paradigm as in A.
(C) In another cell, 1 mM 4AP (bath applied) reduced IKi 68% after 10
min. Test potential was +40 mV. (D) Application of internal 1 mM 4AP
to another cell via an exchange pipette (see Methods) dramatically
blocked IKi after 4 min. Pipette exchange time -3 min. Test potential
was +40 mV.
longed application of 4AP is plotted as a function of 4AP
concentration in Fig. 4 A. 4AP blocked control IKi in a
dose-dependent manner with 50% of the channels blocked
at 210 ,M (open symbols). 3-Aminopyridine (3AP)
produced a similar though less potent block (32% block at
100r A
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0
0
m
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0
m
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n
60 F
300 ,gM; data not shown). In cells treated with NBA to
slow the decay of the macroscopic current, the steady-
state blocking effect of aminopyridines was greatly en-
hanced. For example, whereas 100 ,M 4AP only slightly
reduced peak current in a control cell, it blocked over 50%
of the peak current in an NBA-treated cell (Fig. 4 B).
This enhanced effect of 4AP in NBA-treated cells is
observable over the entire dose range examined (Fig. 4 A,
solid symbols).
Is 4AP block Of IKI voltage
dependent?
As mentioned previously, one of the characteristics of
aminopyridine block of delayed rectifier channels is volt-
age dependence. The block becomes weaker for more
depolarizing membrane potentials (Yeh et al., 1976). To
address this issue for IKi, two tests of the voltage depen-
dence of block were performed. The experiments were (a)
to deliver families of voltage steps and look for differential
block in various regions of the current-voltage relation-
ship, and (b) to vary the holding potential and look for
differences in the degree of block at a fixed test potential.
After prolonged application of aminopyridines during
which a stable block was achieved, peak current-voltage
curves were generated using voltage step families (Fig. 5
B). To minimize any possibility of cumulative inactiva-
tion during the protocol, the steps were delivered at
intervals of greater than 30 s, and to random, rather than
consecutive, voltages. Ratio analysis of the resultant
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FIGURE 4 Aminopyridine block is enhanced by NBA treatment. (A)
Dose-response curve for 4AP block of IKi in control (open circles) and
NBA-treated (solid circles) GH3 cells. Symbols represent mean ± SD
with number of observations indicated for each condition. The lines were
drawn through the data points by a spline interpolation routine. (B)
External 100 MM 4AP produced only a slight change in IKi at +20 mV
under control conditions (upper traces; the faster decaying trace was
obtained in 4AP). In another GH3 cell pretreated with 50 gM external
NBA, 100MuM 4AP induced a 67% reduction of IKi (lower traces).
FIGURE 5 Aminopyridine block of IKi is not dependent on test voltage,
but is influenced by holding potential. (A) Data points represent percent
block (mean + SD) of peak IKi as a function of test potential for control
cells (open circles, 300 AM 4AP, n = 4) or cells pretreated with 50AM
NBA (solid circles, 100MM 4AP, n = 3). (B) Current-voltage relation-
ships for peak 'Ki from a control GH3 cell before (open circles) and after
(solid symbols) exposure to 300 ,uM 4AP. Lines through the data points
are fits of 2nd order polynomials. (C) Percent block of peak IKi for three
cells (mean ± SD) exposed to 200MM 4AP at holding potentials of -60
and -90 mV.
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current-voltage curves in the presence and absence of
4AP indicated only little, if any, voltage dependence
favoring block relief with increasing depolarization (Fig.
5 A). Experiments performed in elevated extracellular
K+ (50-75 mM) to assess block of inward K currents,
likewise failed to show significant voltage dependence.
Although test potentials failed to demonstrate the
voltage dependence seen for other K channels blocked by
aminopyridines, changes in holding potential did affect
the percent block by 4AP. When identical concentrations
of 4AP were applied twice to the same cells while holding
at either - 60 or -90 mV (with recovery periods between
drug applications), a greater percent block was seen at the
more depolarized holding potential (Fig. 5 C). Thus,
whereas test voltage had little influence on the degree of
block, depolarized holding potentials potentiated 4AP
block.
Aminopyridines do not alter
macroscopic activation,
deactivation, or inactivation of
unblocked channels
Several compounds which block sodium channels from
the intracellular side, have been suggested to gain access
to their blocking sites via the aqueous ion pathway,
occlude the passage, and prevent closure of the inactiva-
tion gate (Yeh and Narahashi, 1977; Armstrong and
Croop, 1982). One observation that is characteristic of
this scheme is the progressive slowing of deactivation
kinetics with increasing depolarizing pulse length. We
examined IKi tail currents at -80 mV (50 mM external
K+) after depolarizing prepulses of varying durations in
the presence and absence of 4AP. No differences in either
the deactivation time constants nor the inactivation time
course (determined from the dependence of peak tail
current amplitudes on prepulse duration) were seen.
Likewise, no "hooklike" increases in tail currents were
observed as seen for many open channel blockers (Yeh
and Narahashi, 1977). In addition, we have found no
evidence that in the presence of 4AP, activation of
unblocked IKi channels was altered; i.e., there was no
change in the rate of rise to peak current or the voltage
dependence of peak conductance.
Drug binding can alter ion-channel gating behavior.
Likewise, channel gating can alter drug-receptor binding.
For example, local anesthetics may shift the voltage
dependence of inactivation or slow the recovery from
inactivation of sodium channels (Hille, 1977). Such
observations have been explained by proposing an en-
hanced drug binding to inactivated conformations of the
channel (Hille, 1984). However, the steady-state IKi
inactivation vs. voltage curve was only marginally shifted
by 4AP (Fig. 6 A). To minimize contributions from
spontaneous shifts in gating kinetics sometimes induced
by whole-cell dialysis (Fernandez et al., 1984), control
curves were determined at least 15 min after initiating
whole-cell dialysis and compared with curves obtained
after reaching stable block in 4AP. Control currents were
half-inactivated at - - 54 mV, whereas, currents remain-
ing in the presence of 4AP were half-inactivated at -61
mV. These differences were not significant.
In the presence of aminopyridines,
IKI does not exhibit frequency
dependence
Repetitive voltage stimuli have been shown to induce
accumulation of sodium-channel block by quaternary
derivatives of local anesthetics (Yeh, 1982) and ofcalcium-
channel block by calcium antagonists such as D-600
(Hescheler et al., 1982). In contrast, in the continued
presence of the drug, such procedures cause the relief of
delayed rectifier K channel block by aminopyridines. This
latter finding led to the suggestion that aminopyridines
block closed channels, and are released from open chan-
nels (Yeh et al., 1976). Subsequent studies have, however,
indicated that open delayed rectifier chanrrels are the
likely target for aminopyridine block, and that opening
the channel permits expression of a voltage-dependent
block escape by the charged drug form (Kirsch et al.,
1986). Using protocols similar to those of Yeh et al.
(1976; i.e., repetitive pulses of 0.5-5 Hz) we investigated
dynamic unblock phenomena. Unfortunately, examina-
tion of the effects of repetitive voltage steps (at these
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FIGURE 6 Absence of 4AP effects on 'Ki inactivation. (A) Steady-state
inactivation curves for GH3 cells before (open circles) and after (solid
circles) exposure to 300MuM 4AP. Data represents peak IKi (mean ± SD,
n = 5) at +40 mV after a 2 s prepulse to the indicated potential.
Control data points were obtained following at least 15 min of dialysis.
(B) Time course Of IKi reactivation at -90 mV after a depolarizing
prepulse to 0 mV for 2 s. Data points from 2 cells (triangles and circles)
represent peak IKi normalized to both the control (maximum) and
inactivated (minimum) levels in each case. Open symbols correspond to
control data whereas solid symbols correspond to external exposure to
either 50 ,M NBA (circles) or 300 MM 4AP (triangles). Note that
recovery time is plotted on a logarithmic scale.
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frequencies) on drug block of IKi is complicated by
cumulative inactivation which occurs at interpulse inter-
vals <40 s. We nonetheless executed two tests to evaluate
frequency-dependent block or block relief. Fig. 7 shows
the results of such efforts to reveal 4AP unblock by
repeatedly (1 Hz) giving brief (10 ms) depolarizing pulses
or by giving depolarizing prepulses of various durations
(see Fig. 7 insets for voltage paradigms). In control cells
(Fig. 7 A), repetitive pulses yielded the expected de-
creases in current magnitude, indicating that inactivation
can occur despite the brevity of pulses. (In all cases in this
figure, the largest current is the first in the series of
records.) After application of 4AP, repetitive pulsing or
depolarizing prepulses either slightly decreased the re-
maining current amplitude, or had no effect at all. No
obvious use dependence was seen.
We reasoned that perhaps our failure to observe block
relief with repetitive depolarization (as has been seen for
other types of K channels) was due to a "trapping" of 4AP
molecules in the channels by the closure of the inactiva-
tion gates, or simply due to a balanced expression of two
opposing processes, inactivation and block relief. It fol-
lows that if inactivation could be removed or slowed, then
frequency-dependent phenomena might be unmasked.
Therefore, we internally dialyzed either SITS or NBA
(Oxford and Wagoner, 1989) to slow macroscopic inacti-
vation and reexamined the effects of repetitive pulse
paradigms. Although, as expected, in control cells treated
with SITS or NBA (Fig. 7, B and C), repetitive 10 ms
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FIGURE 7 Aminopyridine block of IK; does not exhibit use dependence.
Upper row of traces represent current responses to 10-ms voltage steps
to +60 mV applied either repetitively (1 Hz, paradigm I) or after
prepulses of increasing duration (5-65 ms) to +40 mV (paradigm II).
Groups of superimposed records are labeled according to the paradigm
employed and the presence of 1 mM 4AP in the bath. Data shown for
three representative cells corresponding to (left to right) control
conditions, and intracellular application of either 1 mM SITS or 1 mM
NBA. Voltage paradigms are diagrammed below current records. For
paradigm I, current traces are the first 3 or 4 in each case, with
subsequent traces (up to 20) showing no change. For paradigm II, traces
are those at 5, 15, and 65 ms.
depolarizing pulses did not produce cumulative inactiva-
tion, after the application of 4AP, there was still no block
relief with depolarizing pulses. There was also no fre-
quency-dependent block.
To complete our evaluation of the kinetic properties of
4AP block, we delivered single long depolarizing pulses in
the presence of 4AP to determine changes in the extent of
block. Prolonged depolarization in either control or NBA-
treated cells did not produce time-dependent reductions
in 4AP block as have been seen for other types of K
currents (data not shown).
In the presence of a continual application of NBA, IKi
will eventually inactivate, although much more slowly
(Oxford and Wagoner, 1989). Therefore, an alternative
hypothesis to explain the absence of voltage- or time-
dependent unblock in NBA-treated cells, is that recovery
from block is rate-limited by the slow process of recovery
from inactivation (reactivation) for the channels underly-
ing IKi. That is, the abnormally prolonged inactivation,
characteristic of these channels, "traps" the aminopyri-
dine molecules at their binding sites. In Fig. 6 B, the
relative magnitudes of the recovery currents in two cells
are plotted as a function of time spent at -90 mV after an
inactivating voltage step (0 mV, 2 s). One cell was
exposed to NBA to slow inactivation whereas the other
was treated with 4AP to block -50% of the channels. It is
apparent that recovery from inactivation remains slow
despite the presence of NBA to slow the onset of inactiva-
tion, or 4AP to block a large portion of the total current.
This observation lends support to the idea that if channels
which bind 4AP can still inactivate or assume an inactiva-
tion-like state, perhaps frequency- and voltage-dependent
behaviors are not observable due to the slow process of
recovery from inactivation.
Recovery from aminopyridine block
Is modulated by voltage and channel
gating
After brief applications (seconds) of 4AP which induce
increases in the rate of decay of the macroscopic current,
complete recovery occurs within seconds and shows no
apparent voltage dependence. However, after a stable
block of the peak current has been achieved, recovery
takes many minutes, is enhanced by very negative holding
potentials, and by activating the current with a positive
voltage step. In Fig. 8, the percent of peak current at +40
mV is plotted as a function of time in a cell exposed to 200
,uM 4AP while holding at -90 or -60 mV. After control
periods, 4AP was applied via a U-tube until a stable
block was achieved. Then the drug was rapidly removed
and perifusion continued for 10 min before the first
recovery test pulse was given. At a holding potential of
-90 mV, more than half of the blocked current recovered
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FIGURE 8 Membrane hyperpolarization enhances recovery from 4AP
block. A GH3 cell was consecutively exposed to 200MgM 4AP at holding
potentials of - 90 mV (horizontal bar, top) or - 60 mV (horizontal bar,
bottom) and allowed to fully recover after each exposure. Data points
represent the percent peak IKi at HP = - 90 mV (solid circles) and - 60
mV (open circles). In each case no depolarizing voltage steps were
delivered during the initial 10 min recovery period in the absence of4AP
(dashed lines). Currents elicited by the second test pulses (b, d) were
significantly larger than those elicited by the first pulses (a, c). During
the recovery from 4AP at -60 mV, the holding potential was switched
from -60 to -90 mV (e), enhancing tle recovery, and then back to
-60 mV for the final point (f ).
with the first test step (a). The second recovery test step
(b), and all subsequent steps from - 90 mV demonstrated
complete (100%) recovery. In contrast, when holding at
-60 mV, only 26% recovery had occurred when the first
recovery test pulse (c) was given. Although with the
second recovery pulse from -60 mV (d), there was a
marked increase in total current, the rate of recovery on
subsequent pulses remained slow. Upon returning the
holding potential to -90 mV (e), the current returned
rapidly to control levels where it remained despite a
return of the holding voltage to -60 mV (f). In
summary, a negative holding potential combined with a
positive voltage step to open channels enhanced recovery
from 4AP block.
DISCUSSION
The nature of the interaction between aminopyridines and
certain subtypes of K channels is a complicated interplay
between membrane potential, channel gating, drug form,
and stimulation rate. This interplay results in such
phenomena as use-dependent unblock (Yeh et al., 1976)
and anomalous depolarization-dependent block restora-
tion (Kirsch et al., 1986). Whereas these observations
have guided the design of voltage protocols used in the
present study, several previously reported drug block
phenomena have not been seen with IKi. Instead, a
transient "open channel block" has been observed that
gives way to an equilibrium reduction of current that
exhibits neither the voltage nor frequency dependence
seen in delayed rectifier channels. Our data suggests that
our inability to detect these phenomena may be a reflec-
tion of the dominance of the inactivated state which serves
to mask behaviors requiring the open state of the channel
as a detector. However, aminopyridines do exhibit a form
of use-dependent block evidenced by the enhanced time-
dependent decay of current during single depolarizations
and the pulse-dependent rates of block and recovery.
Comparison of 4AP block of delayed
rectifier, lA and 'Ki channels
The characteristics of 4AP block ofK channels reflect the
relative rates of channel gating and 4AP binding and
unbinding. Differences in the gating rates of delayed
rectifier, 'A, and IKi channels appear in part to underlie
differences in the expression of voltage or frequency
dependence. For example, in the delayed rectifier potas-
sium channel, the relief from aminopyridine block with
depolarization is slower than normal activation gating.
Likewise, the reestablishment of block with hyperpolariza-
tion is slower than deactivation kinetics. Therefore, fea-
tures such as use-dependent recovery with repetitive
depolarization are seen because channel gating is at
equilibrium during much of the dynamics of the drug-
channel interaction. Because inactivation is not a promi-
nent gating feature of these channels (Chabala, 1984), it
does not significantly influence the block.
Unlike the dissimilar kinetics of gating and 4AP block
of the delayed rectifier potassium current, the voltage-
and time dependence of gating and aminopyridine block
are more comparable for IA. Thus, features of block
dynamics which are easily seen in delayed rectifier chan-
nels (e.g., frequency-dependent unblock), are much less
exaggerated in 'A channels (Thompson, 1982). This
difference appears to be related to the presence of
inactivation which "competes" with drug molecules for
block of the passage: channels are either blocked or
inactivated. Because recovery from inactivation is rapid
in 'A, occurring within 1 s near the resting potential,
repetitive pulsing elicits currents that can reflect drug-
channel interactions rather than cumulative inactivation.
The mirror image voltage relationship for inactivation
and aminopyridine block led Thompson (1982) to propose
that modulation of block by inactivation either reflects
prevention of drug access to the receptor site by a closed
inactivation gate, or dependence of the formation of a
4AP receptor on the open state of the inactivation gate.
The concept that inactivated and drug-blocked channel
states are exclusive was further supported by the observa-
tion that 'A recordings during repetitive pulses in 4AP
exhibited "crossover," such that greater block of peak
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current was associated with less inactivation at longer
times during a pulse. A similar argument has been used to
explain the interactions between monovalent cations and
the inactivation gates of sodium channels (Oxford and
Yeh, 1985).
In IKi of GH3 cells, as in 'A, the onset of aminopyridine
block and of macroscopic inactivation gating are very
similar. Therefore, one might expect to see classic ami-
nopyridine block or unblock phenomena. However, even
in cells treated with NBA to slow inactivation, these
dynamic features are still not readily apparent. This is in
part due to the extremely slow recovery from inactivation
(reactivation) which prevents an unambiguous assess-
ment of block kinetics at stimulation rates comparable to
those used for other channels.
There are at least two possibilities for the failure to see
the classic dynamic features of block and unblock by
aminopyridines. First, just as depolarization opens chan-
nels and draws unblocked channels into an inactivated
conformation from which recovery is slow, blocked chan-
nels may also proceed to a slow "recovery" state in which
aminopyridines become effectively unable to dissociate.
That is, the rate constant for 4AP dissociation from the
channel is extremely slow at all voltages. Alternatively,
blocked channels may still be able to inactivate and thus
cannot conduct regardless of the state of block. This latter
possibility is supported by (a) the identity of reactivation
rates in control, NBA, and 4AP treated cells, (b) the
absence of "hooks" or progressive slowing in IKi tail
currents, and (c) the absence of IKi crossover during
depolarizing pulses when 4AP records are compared to
controls.
The binding site(s) for
aminopyridines in IKI channels
In IKi, 4AP produces, on a millisecond time scale, both
transient open-channel block (reflected by faster decay of
the current), and a steady-state block (reflected by a
decrease in peak IK), which are concentration dependent
(Figs. 1 and 4). The steady-state block can apparently
proceed from the closed state, although very slowly (Fig.
2). This dual nature of 4AP block suggests that either two
binding sites exist in or near the channel, or two pathways
are available for the drug to reach a common binding site.
Perhaps there are both hydrophilic and hydrophobic
pathways for the aminopyridine drug/receptor interac-
tion, one via the open K channel, and one through the lipid
bilayer or channel wall. Our data do not allow discrimina-
tion between these possibilities. The apparent increase in
sensitivity to 4AP block in NBA-treated cells likely
reflects the increase in open channel probability induced
by NBA (Oxford and Wagoner, 1989), and, therefore,
the time for drug binding to open channels. The dual
nature of block is also apparent in the investigation of
recovery from block. Only a portion of the total peak
current recovers unless depolarizing pulses are given at
frequencies which do not produce cumulative inactiva-
tion.
The effect of holding potentials on the percent of
steady-state block and block recovery reflect the impor-
tance of both channel opening and the slow process of
recovery from inactivation to the kinetics of 4AP block.
Channel-opening probability is likely higher at -60 mV
than -90 mV and, thus, even without activation of
currents detectable at the macroscopic level, more chan-
nels should be available for "open channel block" mecha-
nisms. This is consistent with the observation that the
degree of block is greater for more depolarizing holding
potentials. A similar conclusion was reached by Kirsch et
al. (1986) for the effects of holding potential on aminopy-
ridine block of delayed rectifier channels. Additionally, at
-60 mV, almost half of the available channels move into
the inactivated state, and the rate of reactivation is
relatively slow. If 4AP molecules are "trapped" by the
inactivated state of the channel, this should also contrib-
ute to the enhanced steady-state block at this holding
potential. Channels are less likely to escape inactivation
at -60 mV than at -90 mV and, thus, clear themselves
of 4AP. Accordingly, the rate of recovery from 4AP block
is slower at -60 mV than at -90 mV. The effect of
membrane hyperpolarization (which removes inactiva-
tion) to enhance recovery from block is similar to that
seen for the recovery from local anesthetic block (Hille,
1977).
In summary, we have described aminopyridine block of
a K current having slow inactivation recovery kinetics.
This block is unique in its simplicity, lacking some of the
voltage and frequency-dependent characteristics found
for other K channel subtypes. However, channel gating
phenomena do influence the rate and degree of the block.
4AP block of IKi apparently proceeds and recovers from
both closed and open channel states and is enhanced by
compounds such as NBA which slow the macroscopic
current decay.
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